You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLC Buy Disclosure
Trieu Vuong · SEC Form 4 · Filed Jun 17, 2026
Buy
Calculated transaction value
$4.32K
Trieu Vuong Chairman And CEO
OTLC
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
OTLC daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 96,000 shares @ $0.04
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-029137
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$15.01K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oncotelic Therapeutics, Inc. OTLC | Buy | Jun 17, 2026 | $10.69K |
| Oncotelic Therapeutics, Inc. OTLC Current | Buy | Jun 15, 2026 | $4.32K |